-
1
-
-
0024990658
-
Role of vasopressin in cardiovascular and blood pressure regulation
-
Abboud F.M., Floras J.S., Aylward P.E., Guo G.B., Gupta B.N., Schmid P.G. Role of vasopressin in cardiovascular and blood pressure regulation. Blood Vessels. 27:1990;106-115.
-
(1990)
Blood Vessels
, vol.27
, pp. 106-115
-
-
Abboud, F.M.1
Floras, J.S.2
Aylward, P.E.3
Guo, G.B.4
Gupta, B.N.5
Schmid, P.G.6
-
2
-
-
0019434276
-
Vascular effects of arginine vasopressin during fluid deprivation in the rat
-
Aisenbrey G.A., Handelman W.A., Arnold P., Manning M., Schrier R.W. Vascular effects of arginine vasopressin during fluid deprivation in the rat. J. Clin. Invest. 67:1981;961-968.
-
(1981)
J. Clin. Invest.
, vol.67
, pp. 961-968
-
-
Aisenbrey, G.A.1
Handelman, W.A.2
Arnold, P.3
Manning, M.4
Schrier, R.W.5
-
3
-
-
0019379071
-
Relative contributions of arginine vasopressin and angiotensin II to maintenance of systemic arterial pressure in the anesthetized water-deprived rat
-
Andrews C.E. Jr., Berner B.M. Relative contributions of arginine vasopressin and angiotensin II to maintenance of systemic arterial pressure in the anesthetized water-deprived rat. Circ. Res. 48:1981;254-258.
-
(1981)
Circ. Res.
, vol.48
, pp. 254-258
-
-
Andrews C.E., Jr.1
Berner, B.M.2
-
5
-
-
0015153989
-
Pitressin-induced myocardial injury and depression in a young woman
-
Beller B.M., Trevino A., Urban E. Pitressin-induced myocardial injury and depression in a young woman. Am. J. Med. 51:1971;675-679.
-
(1971)
Am. J. Med.
, vol.51
, pp. 675-679
-
-
Beller, B.M.1
Trevino, A.2
Urban, E.3
-
6
-
-
0020064251
-
Vasopressin and vascular reactivity in the development of DOCA hypertension in rats with hereditary diabetes insipidus
-
Berecek K.H., Murray R.D., Gross F., Brody M.J. Vasopressin and vascular reactivity in the development of DOCA hypertension in rats with hereditary diabetes insipidus. Hypertension. 4:1982;3-12.
-
(1982)
Hypertension
, vol.4
, pp. 3-12
-
-
Berecek, K.H.1
Murray, R.D.2
Gross, F.3
Brody, M.J.4
-
7
-
-
0022979657
-
Direct cardiac effects of vasopressin and their reversal by vascular antagonist
-
Boyle W.A. III, Segel L.D. Direct cardiac effects of vasopressin and their reversal by vascular antagonist. Am. J. Physiol. 251:1986;H734-H741.
-
(1986)
Am. J. Physiol.
, vol.251
-
-
Boyle W.A. III1
Segel, L.D.2
-
8
-
-
0034069082
-
Vasopressin receptor antagonism - A therapeutic option in heart failure and hypertension
-
Burrell L.M., Risvanis J., Johnston C.I., Naitoh M., Balding L.C. Vasopressin receptor antagonism - a therapeutic option in heart failure and hypertension. Exp. Physiol. 85:2000;259S-265S.
-
(2000)
Exp. Physiol.
, vol.85
-
-
Burrell, L.M.1
Risvanis, J.2
Johnston, C.I.3
Naitoh, M.4
Balding, L.C.5
-
10
-
-
0024311614
-
Phorbol esters and arginine vasopressin in vascular smooth muscle cell activation
-
Caramelo C., Okada K., Tsai P., Schrier R.W. Phorbol esters and arginine vasopressin in vascular smooth muscle cell activation. Am. J. Physiol. 256:1989;F875-F881.
-
(1989)
Am. J. Physiol.
, vol.256
-
-
Caramelo, C.1
Okada, K.2
Tsai, P.3
Schrier, R.W.4
-
13
-
-
0018288301
-
The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat
-
Crofton J.T., Share L., Shade R.E., Lee-Kwon W.J., Manning M., Sawyer W.H. The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat. Hypertension. 1:1979;31-38.
-
(1979)
Hypertension
, vol.1
, pp. 31-38
-
-
Crofton, J.T.1
Share, L.2
Shade, R.E.3
Lee-Kwon, W.J.4
Manning, M.5
Sawyer, W.H.6
-
14
-
-
0028178199
-
Plasma corticotrophin releasing hormone, vasopressin, ACTH and cortisol responses to acute myocardial infarction
-
Donald R.A., Crozier I.G., Foy S.G., Richards A.M., Livesey J.H., Ellis M.J.et al. Plasma corticotrophin releasing hormone, vasopressin, ACTH and cortisol responses to acute myocardial infarction. Clin. Endocrinol. (Oxf.). 40:1994;499-504.
-
(1994)
Clin. Endocrinol. (Oxf.)
, vol.40
, pp. 499-504
-
-
Donald, R.A.1
Crozier, I.G.2
Foy, S.G.3
Richards, A.M.4
Livesey, J.H.5
Ellis, M.J.6
-
15
-
-
0029998212
-
Regional differences in the arterial response to vasopressin: Role of endothelial nitric oxide
-
Garcia-Villalon A.L., Garcia J.L., Fernandez N., Monge L., Gomez B., Dieguez G. Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide. Br. J. Pharmacol. 118:1996;1848-1854.
-
(1996)
Br. J. Pharmacol.
, vol.118
, pp. 1848-1854
-
-
Garcia-Villalon, A.L.1
Garcia, J.L.2
Fernandez, N.3
Monge, L.4
Gomez, B.5
Dieguez, G.6
-
16
-
-
0022512331
-
Hemodynamic effects of infused arginine vasopressin in congestive heart failure
-
Goldsmith S.R., Francis G.S., Cowley A.W. Jr., Goldenberg I.F., Cohn J.N. Hemodynamic effects of infused arginine vasopressin in congestive heart failure. J. Am. Coll. Cardiol. 8:1986;779-783.
-
(1986)
J. Am. Coll. Cardiol.
, vol.8
, pp. 779-783
-
-
Goldsmith, S.R.1
Francis, G.S.2
Cowley A.W., Jr.3
Goldenberg, I.F.4
Cohn, J.N.5
-
19
-
-
0032840751
-
Endothelin-1 stimulates proliferation of human coronary smooth muscle cells via the ETA receptor and is co-mitogenic with growth factors
-
Hafizi S., Allen S.P., Goodwin A.T., Chester A.H., Yacoub M.H. Endothelin-1 stimulates proliferation of human coronary smooth muscle cells via the ETA receptor and is co-mitogenic with growth factors. Atherosclerosis. 146:1999;351-359.
-
(1999)
Atherosclerosis
, vol.146
, pp. 351-359
-
-
Hafizi, S.1
Allen, S.P.2
Goodwin, A.T.3
Chester, A.H.4
Yacoub, M.H.5
-
20
-
-
0031838129
-
Growth response of human coronary smooth muscle cells to angiotensin II and influence of angiotensin AT1 receptor blockade
-
Hafizi S., Chester A.H., Allen S.P., Morgan K., Yacoub M.H. Growth response of human coronary smooth muscle cells to angiotensin II and influence of angiotensin AT1 receptor blockade. Coron. Artery Dis. 9:1998;167-175.
-
(1998)
Coron. Artery Dis.
, vol.9
, pp. 167-175
-
-
Hafizi, S.1
Chester, A.H.2
Allen, S.P.3
Morgan, K.4
Yacoub, M.H.5
-
21
-
-
0347415194
-
Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs
-
Heyndrickx G.R., Boettcher D.H., Vatner S.F. Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am. J. Physiol. 231:1976;1579-1587.
-
(1976)
Am. J. Physiol.
, vol.231
, pp. 1579-1587
-
-
Heyndrickx, G.R.1
Boettcher, D.H.2
Vatner, S.F.3
-
23
-
-
0022048191
-
Effects of vasopressin on the coronary circulation: Reserve and regulation during ischemia
-
Khayyal M.A., Eng C., Franzen D., Breall J.A., Kirk E.S. Effects of vasopressin on the coronary circulation: reserve and regulation during ischemia. Am. J. Physiol. 248:1985;H516-H522.
-
(1985)
Am. J. Physiol.
, vol.248
-
-
Khayyal, M.A.1
Eng, C.2
Franzen, D.3
Breall, J.A.4
Kirk, E.S.5
-
24
-
-
0026460407
-
Inhibitory effect of a novel antianginal agent, E4080, on ST segment elevation induced by vasopressin in anesthetized guinea pigs
-
Kodama K., Adachi H., Ogawa T., Ohhara H. Inhibitory effect of a novel antianginal agent, E4080, on ST segment elevation induced by vasopressin in anesthetized guinea pigs. Jpn. J. Pharmacol. 60:1992;73-77.
-
(1992)
Jpn. J. Pharmacol.
, vol.60
, pp. 73-77
-
-
Kodama, K.1
Adachi, H.2
Ogawa, T.3
Ohhara, H.4
-
27
-
-
0026062086
-
Pharmacology and clinical perspectives of vasopressin antagonists
-
Laszlo F.A., Laszlo F. Jr., De Wied D. Pharmacology and clinical perspectives of vasopressin antagonists. Pharmacol. Rev. 43:1991;73-108.
-
(1991)
Pharmacol. Rev.
, vol.43
, pp. 73-108
-
-
Laszlo, F.A.1
Laszlo F., Jr.2
De Wied, D.3
-
28
-
-
0025816917
-
Endogenous vasoconstrictor prostanoids: Role in serotonin and vasopressin-induced coronary vasoconstriction
-
Lee S.L., Levitsky S., Feinberg H. Endogenous vasoconstrictor prostanoids: role in serotonin and vasopressin-induced coronary vasoconstriction. J. Pharmacol. Exp. Ther. 258:1991;292-298.
-
(1991)
J. Pharmacol. Exp. Ther.
, vol.258
, pp. 292-298
-
-
Lee, S.L.1
Levitsky, S.2
Feinberg, H.3
-
29
-
-
0022483750
-
Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs
-
Liard J.F. Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs. Circ. Res. 58:1986;631-640.
-
(1986)
Circ. Res.
, vol.58
, pp. 631-640
-
-
Liard, J.F.1
-
30
-
-
0024801647
-
Discovery, development, and some uses of vasopressin and oxytocin antagonists
-
Manning M., Sawyer W.H. Discovery, development, and some uses of vasopressin and oxytocin antagonists. J. Lab. Clin. Med. 114:1989;617-632.
-
(1989)
J. Lab. Clin. Med.
, vol.114
, pp. 617-632
-
-
Manning, M.1
Sawyer, W.H.2
-
31
-
-
0025764802
-
Coronary vasoconstriction induced by vasopressin. Production of myocardial ischemia in dogs by constriction of nondiseased small vessels
-
Maturi M.F., Martin S.E., Markle D., Maxwell M., Burruss C.R., Speir E.et al. Coronary vasoconstriction induced by vasopressin. Production of myocardial ischemia in dogs by constriction of nondiseased small vessels. Circulation. 83:1991;2111-2121.
-
(1991)
Circulation
, vol.83
, pp. 2111-2121
-
-
Maturi, M.F.1
Martin, S.E.2
Markle, D.3
Maxwell, M.4
Burruss, C.R.5
Speir, E.6
-
32
-
-
0018666457
-
Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin
-
Michell R.H., Kirk C.J., Billah M.M. Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin. Biochem. Soc. Trans. 7:1979;861-865.
-
(1979)
Biochem. Soc. Trans.
, vol.7
, pp. 861-865
-
-
Michell, R.H.1
Kirk, C.J.2
Billah, M.M.3
-
34
-
-
0024434106
-
Characteristics of canine coronary resistance arteries: Importance of endothelium
-
Myers P.R., Banitt P.F., Guerra R. Jr., Harrison D.G. Characteristics of canine coronary resistance arteries: Importance of endothelium. Am. J. Physiol. 257:1989;H603-H610.
-
(1989)
Am. J. Physiol.
, vol.257
-
-
Myers, P.R.1
Banitt, P.F.2
Guerra R., Jr.3
Harrison, D.G.4
-
35
-
-
0014103329
-
Studies on the cardiovascular effects of synthetic vasopressin
-
Nakano J. Studies on the cardiovascular effects of synthetic vasopressin. J. Pharmacol. Exp. Ther. 157:1967;19-31.
-
(1967)
J. Pharmacol. Exp. Ther.
, vol.157
, pp. 19-31
-
-
Nakano, J.1
-
36
-
-
85047679683
-
Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies
-
Newby A.C., George S.J. Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies. Cardiovasc. Res. 27:1993;1173-1183.
-
(1993)
Cardiovasc. Res.
, vol.27
, pp. 1173-1183
-
-
Newby, A.C.1
George, S.J.2
-
37
-
-
0013884498
-
Assay of antianginal drugs by relieving pituitrin induced coronary vasoconstriction in the intact unanaesthetized animal
-
Papp J., Szekeres L. Assay of antianginal drugs by relieving pituitrin induced coronary vasoconstriction in the intact unanaesthetized animal. Arch. Int. Pharmacodyn. Ther. 160:1966;147-158.
-
(1966)
Arch. Int. Pharmacodyn. Ther.
, vol.160
, pp. 147-158
-
-
Papp, J.1
Szekeres, L.2
-
38
-
-
0026508732
-
1 receptor of rat, rhesus and human tissues
-
1 receptor of rat, rhesus and human tissues. Life Sci. 50:1992;1953-1958.
-
(1992)
Life Sci.
, vol.50
, pp. 1953-1958
-
-
Pettibone, D.J.1
Kishel, M.T.2
Woyden, C.J.3
Clineschmidt, B.V.4
Bock, M.G.5
Freidinger, R.M.6
-
39
-
-
0025684637
-
Selective vasopressin inhibition in rats with heart failure decreases afterload and results in venodilatation
-
Raya T.E., Gay R.G., Goldman S. Selective vasopressin inhibition in rats with heart failure decreases afterload and results in venodilatation. J. Pharmacol. Exp. Ther. 255:1990;1015-1020.
-
(1990)
J. Pharmacol. Exp. Ther.
, vol.255
, pp. 1015-1020
-
-
Raya, T.E.1
Gay, R.G.2
Goldman, S.3
-
40
-
-
0027241856
-
The pathogenesis of atherosclerosis: A perspective for the 1990s
-
Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
-
(1993)
Nature
, vol.362
, pp. 801-809
-
-
Ross, R.1
-
41
-
-
0016280918
-
Regional vascular effects of vasopressin: Plasma levels and circulatory responses
-
Schmid P.G., Abboud F.M., Wendling M.G., Ramberg E.S., Mark A.L., Heistad D.D.et al. Regional vascular effects of vasopressin: plasma levels and circulatory responses. Am. J. Physiol. 227:1974;998-1004.
-
(1974)
Am. J. Physiol.
, vol.227
, pp. 998-1004
-
-
Schmid, P.G.1
Abboud, F.M.2
Wendling, M.G.3
Ramberg, E.S.4
Mark, A.L.5
Heistad, D.D.6
-
42
-
-
0011226111
-
Coronary vascular responses to physiological levels of vasopressin
-
Schmid P.G., Wendling M.G., Mark A.L., Eckstein J.W., Abboud F.M. Coronary vascular responses to physiological levels of vasopressin. Circulation. 42(Suppl III):1970;196.
-
(1970)
Circulation
, vol.42
, Issue.SUPPL. III
, pp. 196
-
-
Schmid, P.G.1
Wendling, M.G.2
Mark, A.L.3
Eckstein, J.W.4
Abboud, F.M.5
-
43
-
-
0022152966
-
Hemodynamic effects of neurohypophyseal peptides with antidiuretic activity in dogs
-
Schwartz J., Liard J.F., Ott C., Cowley A.W. Jr. Hemodynamic effects of neurohypophyseal peptides with antidiuretic activity in dogs. Am. J. Physiol. 249:1985;H1001-H1008.
-
(1985)
Am. J. Physiol.
, vol.249
-
-
Schwartz, J.1
Liard, J.F.2
Ott, C.3
Cowley A.W., Jr.4
-
44
-
-
0019824002
-
Effect of vasopressin blockade on blood pressure regulation during hemorrhage in conscious dogs
-
Schwartz J., Reid I.A. Effect of vasopressin blockade on blood pressure regulation during hemorrhage in conscious dogs. Endocrinology. 109:1981;1778-1780.
-
(1981)
Endocrinology
, vol.109
, pp. 1778-1780
-
-
Schwartz, J.1
Reid, I.A.2
-
45
-
-
0020686644
-
Role of vasopressin in blood pressure regulation in conscious water-deprived dogs
-
Schwartz J., Reid I.A. Role of vasopressin in blood pressure regulation in conscious water-deprived dogs. Am. J. Physiol. 244:1983;R74-R77.
-
(1983)
Am. J. Physiol.
, vol.244
-
-
Schwartz, J.1
Reid, I.A.2
-
50
-
-
0033647332
-
2 receptors: Synthesis and pharmacological properties of 4′-(4,4-difluoro-5-methylidene-2,3,4,5-tetrahydro-1H-1-benzoazepin-1- yl)carbonyl)-2-phenylbenzanilide derivatives
-
2 receptors: synthesis and pharmacological properties of 4′-(4,4-difluoro-5-methylidene-2,3,4,5-tetrahydro-1H-1-benzoazepin-1- yl)carbonyl)-2-phenylbenzanilide derivatives. Chem. Pharm. Bull. 48:2000;1644-1651.
-
(2000)
Chem. Pharm. Bull.
, vol.48
, pp. 1644-1651
-
-
Shimada, Y.1
Taniguchi, N.2
Matsuhisa, A.3
Sakamoto, K.4
Yatsu, T.5
Tanaka, A.6
-
51
-
-
0026524460
-
Characterization of a vasopressin-like peptide in rat and bovine blood vessels
-
Simon J.S., Brody M.J., Kasson B.G. Characterization of a vasopressin-like peptide in rat and bovine blood vessels. Am. J. Physiol. 262:1992;H799-H805.
-
(1992)
Am. J. Physiol.
, vol.262
-
-
Simon, J.S.1
Brody, M.J.2
Kasson, B.G.3
-
52
-
-
0019861237
-
Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure
-
Szatalowicz V.L., Arnold P.E., Chaimovitz C., Bichet D., Berl T., Schrier R.W. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N. Engl. J. Med. 305:1981;263-266.
-
(1981)
N. Engl. J. Med.
, vol.305
, pp. 263-266
-
-
Szatalowicz, V.L.1
Arnold, P.E.2
Chaimovitz, C.3
Bichet, D.4
Berl, T.5
Schrier, R.W.6
-
53
-
-
0031405967
-
Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced hyperplasia and hypertrophy of cultured vascular smooth-muscle cells
-
Tahara A., Tomura Y., Wada K., Kusayama T., Tsukada J., Ishii N.et al. Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced hyperplasia and hypertrophy of cultured vascular smooth-muscle cells. J. Cardiovasc. Pharmacol. 30:1997;759-766.
-
(1997)
J. Cardiovasc. Pharmacol.
, vol.30
, pp. 759-766
-
-
Tahara, A.1
Tomura, Y.2
Wada, K.3
Kusayama, T.4
Tsukada, J.5
Ishii, N.6
-
54
-
-
0030770540
-
2 receptor antagonist, in vitro and in vivo
-
2 receptor antagonist, in vitro and in vivo. J. Pharmacol. Exp. Ther. 282:1997;301-308.
-
(1997)
J. Pharmacol. Exp. Ther.
, vol.282
, pp. 301-308
-
-
Tahara, A.1
Tomura, Y.2
Wada, K.3
Kusayama, T.4
Tsukada, J.5
Takanashi, M.6
-
56
-
-
0022508478
-
Evidence for a vasodilatory effect of vasopressin in the conscious rat
-
Walker B.R. Evidence for a vasodilatory effect of vasopressin in the conscious rat. Am. J. Physiol. 251:1986;H34-H39.
-
(1986)
Am. J. Physiol.
, vol.251
-
-
Walker, B.R.1
-
61
-
-
0032988191
-
2 receptor antagonist, in dogs with pacing-induced congestive heart failure
-
2 receptor antagonist, in dogs with pacing-induced congestive heart failure. Eur. J. Pharmacol. 376:1999;239-246.
-
(1999)
Eur. J. Pharmacol.
, vol.376
, pp. 239-246
-
-
Yatsu, T.1
Tomura, Y.2
Tahara, A.3
Wada, K.4
Kusayama, T.5
Tsukada, J.6
|